The application of discrete choice experiments in cost-effectiveness studies to assess the benefits of sensor-augmented insulin pump therapy for the treatment of type 1 diabetes
Background and Aims: Diabetes Mellitus affects over 630 million people worldwide and is directly attributed to 1.5 mil- lion deaths annually. Few studies have been conducted to determine the cost-effectiveness of gold-standard type 1 diabetes treatment resulting in low uptake among countries that do...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
2016
|
| Online Access: | http://hdl.handle.net/20.500.11937/21907 |
| _version_ | 1848750722198274048 |
|---|---|
| author | Barnett, N. Geelhoed, E. Davis, E. Jones, T. De Bock, M. Smith, G. Norman, Richard |
| author_facet | Barnett, N. Geelhoed, E. Davis, E. Jones, T. De Bock, M. Smith, G. Norman, Richard |
| author_sort | Barnett, N. |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | Background and Aims: Diabetes Mellitus affects over 630 million people worldwide and is directly attributed to 1.5 mil- lion deaths annually. Few studies have been conducted to determine the cost-effectiveness of gold-standard type 1 diabetes treatment resulting in low uptake among countries that do not provide subsidised access to patients. Discrete choice experiments (DCE) are an innovative measurement tool applied in a number of fields, however their application in health treatment lags. DCEs can be used to explore preferences towards alter- native treatment options and to determine relative cost-effectiveness using a holistic measure of relative attributes in the decision-making process. Method: A literature review was undertaken to identify the application of discrete choice experiments to evaluate preferences in type 1 diabetes treatments. Search terms were restricted to studies on type 1 diabetes but were not limited on any other basis. Results: Three papers contained the terms ‘discrete choice experiment’ and ‘type 1 diabetes’ from relevant databases. At present there are no studies that analyse the cost-effectiveness of type 1 diabetes treatment using a discrete choice experiment methodology. Conclusion: A significant gap in the literature suggests there is scope for a discrete choice experiment to be conducted with patients and parents of children suffering from type 1 diabetes. An applied DCE would contribute valuable insights into the benefit measurement of gold-standard therapies and may improve access if cost-effectiveness is demonstrated |
| first_indexed | 2025-11-14T07:41:21Z |
| format | Journal Article |
| id | curtin-20.500.11937-21907 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T07:41:21Z |
| publishDate | 2016 |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-219072017-01-30T12:28:09Z The application of discrete choice experiments in cost-effectiveness studies to assess the benefits of sensor-augmented insulin pump therapy for the treatment of type 1 diabetes Barnett, N. Geelhoed, E. Davis, E. Jones, T. De Bock, M. Smith, G. Norman, Richard Background and Aims: Diabetes Mellitus affects over 630 million people worldwide and is directly attributed to 1.5 mil- lion deaths annually. Few studies have been conducted to determine the cost-effectiveness of gold-standard type 1 diabetes treatment resulting in low uptake among countries that do not provide subsidised access to patients. Discrete choice experiments (DCE) are an innovative measurement tool applied in a number of fields, however their application in health treatment lags. DCEs can be used to explore preferences towards alter- native treatment options and to determine relative cost-effectiveness using a holistic measure of relative attributes in the decision-making process. Method: A literature review was undertaken to identify the application of discrete choice experiments to evaluate preferences in type 1 diabetes treatments. Search terms were restricted to studies on type 1 diabetes but were not limited on any other basis. Results: Three papers contained the terms ‘discrete choice experiment’ and ‘type 1 diabetes’ from relevant databases. At present there are no studies that analyse the cost-effectiveness of type 1 diabetes treatment using a discrete choice experiment methodology. Conclusion: A significant gap in the literature suggests there is scope for a discrete choice experiment to be conducted with patients and parents of children suffering from type 1 diabetes. An applied DCE would contribute valuable insights into the benefit measurement of gold-standard therapies and may improve access if cost-effectiveness is demonstrated 2016 Journal Article http://hdl.handle.net/20.500.11937/21907 restricted |
| spellingShingle | Barnett, N. Geelhoed, E. Davis, E. Jones, T. De Bock, M. Smith, G. Norman, Richard The application of discrete choice experiments in cost-effectiveness studies to assess the benefits of sensor-augmented insulin pump therapy for the treatment of type 1 diabetes |
| title | The application of discrete choice experiments in cost-effectiveness studies to assess the benefits of sensor-augmented insulin pump therapy for the treatment of type 1 diabetes |
| title_full | The application of discrete choice experiments in cost-effectiveness studies to assess the benefits of sensor-augmented insulin pump therapy for the treatment of type 1 diabetes |
| title_fullStr | The application of discrete choice experiments in cost-effectiveness studies to assess the benefits of sensor-augmented insulin pump therapy for the treatment of type 1 diabetes |
| title_full_unstemmed | The application of discrete choice experiments in cost-effectiveness studies to assess the benefits of sensor-augmented insulin pump therapy for the treatment of type 1 diabetes |
| title_short | The application of discrete choice experiments in cost-effectiveness studies to assess the benefits of sensor-augmented insulin pump therapy for the treatment of type 1 diabetes |
| title_sort | application of discrete choice experiments in cost-effectiveness studies to assess the benefits of sensor-augmented insulin pump therapy for the treatment of type 1 diabetes |
| url | http://hdl.handle.net/20.500.11937/21907 |